Olam Group (SGX:OLAG) announced plans to exit its agribusiness unit, Olam Agri Holdings, by selling a 44.6% stake to Saudi Agricultural and Livestock Investment Company (SALIC) for $1.78 billion. This deal values Olam Agri at $4 billion and is expected to close in Q4 2025.
With this transaction, SALIC will gain an 80.01% controlling stake, while Olam intends to divest its remaining 19.99% stake within three years at the closing valuation. The full exit is expected to generate up to $3.87 billion in gross proceeds, which Olam may use for debt reduction or a potential special dividend.
Olam will retain full ownership of its other businesses, including its fast-growing ingredients unit, ofi. CEO Sunny Verghese emphasized that the deal enables Olam to focus on unlocking value for its remaining businesses and pursuing a potential IPO for ofi.
Rothschild & Co, Citigroup (NYSE:C), and HSBC advised Olam on the transaction.


CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Washington Post Publisher Will Lewis Steps Down After Layoffs
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Instagram Outage Disrupts Thousands of U.S. Users
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 



